Andrikopoulou, Maria, Elisa T. Bushman, Madeline M. Rice, William A. Grobman, Uma M. Reddy, Robert M. Silver, Yasser Y. El-Sayed, et al. “Maternal and Neonatal Outcomes in Nulliparous Participants Undergoing Labor Induction by Cervical Ripening Method.” Am J Perinatol, August 5, 2021. https://doi.org/10.1055/s-0041-1732379.
Geeta Krishna Swamy, MD
Professor of Obstetrics and Gynecology
Campus Mail:
Box 3967 Med Ctr, Durham, NC 27710
Phone:
(919) 681-5220
Email:
swamy002@mc.duke.edu
Dr. Geeta Swamy, MD, became Vice Chair for Research and Faculty Development in the Department of Obstetrics and Gynecology on March 1, 2018. In this dual role, Dr. Swamy oversees strategic development and administration of the Department’s basic, translational and clinical research programs, as well as implements and oversees programs to support development and mentorship for all faculty at all levels.
Dr. Swamy has also been instrumental in developing and leading the School of Medicine’s Research Regulatory and Compliance initiatives, first as Chair of the IRB and then as Senior Associate Dean for Clinical Research for Regulatory Oversight and Research Initiatives. In 2018, she became Vice Dean for Scientific Integrity and Associate Vice President for Research for Duke University. In these roles she oversees the Duke Office of Scientific Integrity (DOSI) which houses the Advancing Scientific Integrity, Services, & Training (ASIST) initiative, conflict of interest, clinical quality management, incident response in research, and research misconduct. She also oversees the Duke Office of Research Initiatives which includes the research onboarding and navigation programs.
Dr. Swamy has dedicated her career to advancing research in women’s health and to mentoring faculty and trainees. She is an internationally recognized clinician-researcher, and an expert and nationally-recognized leader in the field of maternal immunization and vaccination in pregnancy. Her research has been funded by the National Institutes of Health (NIH), Centers for Disease Control (CDC), Environmental Protection Agency (EPA) and others. She currently serves as the Co-Principal Investigator for the NIH-NIAID Vaccine Treatment and Evaluation (VTEU) and CDC-funded Clinical Immunization Safety Assessment, and has published over 100 peer-reviewed manuscripts. Dr. Swamy has been the Director of the Duke Perinatal Research Center since 2010. Dr. Swamy's focused area of interests are perinatal infection, maternal immunization and preterm birth.
Education and Training
- Resident, Obstetrics And Gynecology, University of Pittsburgh, 1997 - 2001
- M.D., University of North Carolina - Chapel Hill, 1997
Selected Grants and Awards
- Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women
- Population Health Research Support IDIQ Base
- Duke Women's Reproductive Health Research Scholars
- "An adaptive prenatal (ADEPT) intervention to encourage childhood vaccinations
- 2020 CISA 04-COVID Maternal Study
- Vaccine and Treatment Evaluation Units (VTEU)
- Duke CTSA (TL1)
- Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
- CISA 2021-2022- Clinical Consult CLIN 4002 - Optional Task 1, Option Year 4
- CISA 2018-2019- Clinical Consult - Opt 1
- RTOP 2018 CISA 01 Flublok Lead Task 2
- RTOP 2018 CISA 01 Flublok Lead Task 3
- RTOP 2018 CISA 01 Flublok Lead Task 4
- Pulmonary Complications in a Birth Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study Capitation
- VTEU TO #132 Base - HHSN272201300017I TO 75N93019F00132 Task Area A - FY.2020.A1B1C1D1.0123 - Option 2.A
- Population Health Research Support - Study of Pregnancy and Neonatal Health (SPAN) Task A
- Affecting Culture Change: Building Unit-Level Infrastructure to Mitigate Research Integrity Risk
- CIVICS Component C - Option 1
- RTOP 2018 CISA 01 Flublok Lead Base
- RTOP 2018 CISA 01 Flublok Lead Task 1
- Adaptive COVID-19 Treatment Trial (ACTT)
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Option 1
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- VTEU Task Area C Option 2-3 Protocol 15-0020.B1C1.0040
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- VTEU Protocol Implementation Option 1
- The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcome
- MFMU Network Study - ALPS FSN
- NICHD Maternal Fetal Medicine Units Network
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base-A
- Rapid, Near Patient Nucleic Acid Testing for Infant Cytomegalovirus (CMV) Infection
- RSV- M-301
- VTEU Task Area C Option 2-2 Protocol 15-0020.B1C1.0040
- VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base
- MFMU Network Studies
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead)
- Duke Research Training Program for Pediatricians
- Duke CTSA (UL1)
- RSV-M-203: Study M-203 - A Phase II Randomized, Observer-blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) Fusion (F)
- CISA Task Order No. 3 Tdap Safety in Pregnant Women
- A Phase II, Multicenter, Randomized, Observer-Blind, Controlled Study to Evaluate Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
- SAFETY AND IMMUNOGENICITY OF TDAP VACCINE IN HEALTHY PREGNANT WOMEN, SAFETY IN THEIR NEONATES, AND EFFECT OF MATERNAL IMMUNIZATION ON INFANT IMMUNE RESPONSES TO DTAP VACCINE - DMID 05-0048
- DMID 09-0005 Safety and Immunogenicity
- Effectiveness of a Vaccination Program in the Community ObGyn Setting
- 09-0056 A Phase II Study in Pregnant Women to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Inactivated Influenza Vaccine Administered at Two Dose Levels
- A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant women.
- Prevention of Influenza in Infants by Immunization of Their Contacts in the Household (PIIITCH study)
Publications
Battarbee, Ashley N., Grecio Sandoval, William A. Grobman, Uma M. Reddy, Alan T. N. Tita, Robert M. Silver, Yasser Y. El-Sayed, et al. “Maternal and Neonatal Outcomes Associated with Amniotomy among Nulliparous Women Undergoing Labor Induction at Term.” American Journal of Perinatology 38, no. S 01 (August 2021): e239–48. https://doi.org/10.1055/s-0040-1709464.
Hughes, Brenna L., Rebecca G. Clifton, Dwight J. Rouse, George R. Saade, Mara J. Dinsmoor, Uma M. Reddy, Robert Pass, et al. “A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.” N Engl J Med 385, no. 5 (July 29, 2021): 436–44. https://doi.org/10.1056/NEJMoa1913569.
Guptill, J. T., S. M. Raja, V. C. Juel, E. B. Walter, M. Cohen-Wolkowiez, H. Hill, E. Sendra, B. Hauser, P. Jackson, and G. K. Swamy. “Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.” Antimicrob Agents Chemother 65, no. 7 (June 17, 2021): e0232920. https://doi.org/10.1128/AAC.02329-20.
Gyamfi-Bannerman, Cynthia, Kathleen A. Jablonski, Sean C. Blackwell, Alan T. N. Tita, Uma M. Reddy, Lucky Jain, George R. Saade, et al. “Evaluation of Hypoglycemia in Neonates of Women at Risk for Late Preterm Delivery: An Antenatal Late Preterm Steroids Trial Cohort Study.” American Journal of Perinatology, May 27, 2021. https://doi.org/10.1055/s-0041-1729561.
Craig, Amanda M., Brenna L. Hughes, and Geeta K. Swamy. “Reply to: Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data.” Am J Obstet Gynecol Mfm 3, no. 3 (May 2021): 100323. https://doi.org/10.1016/j.ajogmf.2021.100323.
Craig, Amanda M., Brenna L. Hughes, and Geeta K. Swamy. “Reply: Coronavirus disease 2019 vaccines in pregnancy.” Am J Obstet Gynecol Mfm 3, no. 3 (May 2021): 100337. https://doi.org/10.1016/j.ajogmf.2021.100337.
Craig, Amanda M., Brenna L. Hughes, and Geeta K. Swamy. “Coronavirus disease 2019 vaccines in pregnancy.” Am J Obstet Gynecol Mfm 3, no. 2 (March 2021): 100295. https://doi.org/10.1016/j.ajogmf.2020.100295.
Dotters-Katz, Sarah K., Hailey Harris, Sarahn M. Wheeler, Geeta K. Swamy, and Brenna L. Hughes. “Specialized prenatal care delivery for coronavirus disease 2019-exposed or -infected pregnant women.” Am J Obstet Gynecol 224, no. 3 (March 2021): 325–27. https://doi.org/10.1016/j.ajog.2020.11.025.
Tita, Alan T. N., Lindsay Doherty, William A. Grobman, Uma M. Reddy, Robert M. Silver, Gail Mallett, Madeline Murguia Rice, et al. “Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.” Obstet Gynecol 137, no. 2 (February 1, 2021): 250–57. https://doi.org/10.1097/AOG.0000000000004230.